Research And Development Expense of Quantum Biopharma Ltd. from 31 Dec 2019 to 31 Dec 2024

Taxonomy & unit
ifrs-full: USD
Summary
Quantum Biopharma Ltd. annual and quarterly Research And Development Expense in USD history and change rate from 31 Dec 2019 to 31 Dec 2024.
  • Quantum Biopharma Ltd. Research And Development Expense for the quarter ending 30 Sep 2024 was $744,802, a 2158% increase year-over-year.
  • Quantum Biopharma Ltd. annual Research And Development Expense for 2024 was $6,083,378, a 58% increase from 2023.
  • Quantum Biopharma Ltd. annual Research And Development Expense for 2023 was $3,859,178, a 44% decline from 2022.
  • Quantum Biopharma Ltd. annual Research And Development Expense for 2022 was $6,910,844, a 9.2% increase from 2021.
Source SEC data
View on sec.gov
Research And Development Expense, Annual (USD)
Research And Development Expense, YoY Annual Change (%)
Research And Development Expense, Quarterly (USD)
Research And Development Expense, YoY Quarterly Change (%)

Quantum Biopharma Ltd. Annual Research And Development Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $6,083,378 +$2,224,200 +58% 01 Jan 2024 31 Dec 2024 20-F 28 Mar 2025 2024 FY
2023 $3,859,178 -$3,051,666 -44% 01 Jan 2023 31 Dec 2023 20-F 28 Mar 2025 2024 FY
2022 $6,910,844 +$582,740 +9.2% 01 Jan 2022 31 Dec 2022 20-F 28 Mar 2025 2024 FY
2021 $6,328,104 -$1,504,743 -19% 01 Jan 2021 31 Dec 2021 20-F 02 Apr 2024 2023 FY
2020 $7,832,847 +$7,832,847 01 Jan 2020 31 Dec 2020 20-F 31 Mar 2023 2022 FY
2019 $0 01 Jan 2019 31 Dec 2019 20-F 31 Mar 2022 2021 FY

Quantum Biopharma Ltd. Quarterly Research And Development Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $744,802 +$711,817 +2158% 01 Jul 2024 30 Sep 2024 6-K 12 Nov 2024 2024 Q3
Q2 2024 $897,986 -$712,542 -44% 01 Apr 2024 30 Jun 2024 6-K/A 19 Aug 2024 2024 Q2
Q3 2023 $32,985 01 Jul 2023 30 Sep 2023 6-K 12 Nov 2024 2024 Q3
Q2 2023 $1,610,528 01 Apr 2023 30 Jun 2023 6-K/A 19 Aug 2024 2024 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.